Nicola Vannini, of the Ludwig Institute for Cancer Research Lausanne, with researchers from EPFL, finds that supplementing diet with an analogue of vitamin B3 could improve the treatment of some blood cancers.
Findings of this collaborative research have found that supplementing diet with nicotinamide riboside, an analogue of vitamin B3, boosts the production of blood cells by improving the function of their stem cells. This can help overcome problems in stem cell-based therapies that treat leukemia and aggressive lymphomas.